Concepedia

Lori Roadcap

LR

Statistics

Publications

2

Citations

582

H-Index

2

Active since

2012

Affiliations

Texas Oncology(Current)

Lori Roadcap is an author at Texas Oncology specializing in tumor necrosis factor superfamily, inflammation, and metastatic melanoma treatment.

Publications per year

2012–2020

2

Publications

2

Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial

Gerald S. Falchook, Karl D. Lewis, Jeffrey R. Infante et al. · The Lancet Oncology · 2012 · 542 citations · Full text

, , +17

Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS

David S. Perlin, Inbal Zafir‐Lavie, Lori Roadcap et al. · mSphere · 2020 · 40 citations · Full text

, , +16

1–2 of 2